Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
The Journal of Biological Chemistry|July 10, 1980
An active site-tyrosine-containing heptapeptide from D-amino acid oxidaseS Ronchi, M Galliano, L Minchiotti, et al.
Biophysical Chemistry|September 8, 2014
The complex folding behavior of HIV-1-protease monomer revealed by optical-tweezer single-molecule experiments and molecular dynamics simulationsM Caldarini, P Sonar, I Valpapuram, et al.
The Journal of Biological Chemistry|September 20, 2001
Purification of the aldehyde oxidase homolog 1 (AOH1) protein and cloning of the AOH1 and aldehyde oxidase homolog 2 (AOH2) genes. Identification of a novel molybdo-flavoprotein gene cluster on mouse chromosome 1M Terao, M Kurosaki, M Marini, et al.
International Journal of Oncology|May 11, 2011
Phase i/ii trial of 5-Fluorouracil, leucovorin, Zidovudine and dipyridamole for patients with metastatic colorectal-cancer, renal-cell carcinoma and malignant-melanomaW Sharfman, W Urba, J Smith, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|May 23, 2001
Influence of divalent cations on the catalytic properties and secondary structure of unadenylylated glutamine synthetase from Azospirillum brasilenseL P Antonyuk, V E Smirnova, A A Kamnev, et al.
Journal of the National Cancer Institute|June 3, 1992
Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changesJ B Ochoa, B Curti, A B Peitzman, et al.
Minerva Medica|February 25, 1983
[Computerized methods in the diagnosis and prognosis of surgically treated bilio-pancreatic diseases]T Festa, A Foco, U Serenthà, et al.
Developments in Biologicals|December 18, 2004
Manipulating the host response to autologous tumour vaccinesJ Ma, C H Poehlein, S M Jensen, et al.
Journal for Immunotherapy of Cancer|March 29, 2019
Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM<sup>SM</sup> registryM Fishman, J P Dutcher, J I Clark, et al.
Pageof 6